- Home
- VOR vs WALD Comparison
VOR vs WALD Comparison
Compare VOR & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOR
- WALD
- Stock Information
- Founded
- VOR 2015
- WALD 1988
- Country
- VOR United States
- WALD United States
- Employees
- VOR N/A
- WALD N/A
- Industry
- VOR Biotechnology: Pharmaceutical Preparations
- WALD Package Goods/Cosmetics
- Sector
- VOR Health Care
- WALD Consumer Discretionary
- Exchange
- VOR Nasdaq
- WALD Nasdaq
- Market Cap
- VOR 207.1M
- WALD 228.8M
- IPO Year
- VOR 2021
- WALD 2021
- Fundamental
- Price
- VOR $8.28
- WALD $2.51
- Analyst Decision
- VOR Buy
- WALD Strong Buy
- Analyst Count
- VOR 7
- WALD 5
- Target Price
- VOR $70.43
- WALD $4.76
- AVG Volume (30 Days)
- VOR 1.0M
- WALD 140.5K
- Earning Date
- VOR 11-13-2025
- WALD 11-24-2025
- Dividend Yield
- VOR N/A
- WALD N/A
- EPS Growth
- VOR N/A
- WALD N/A
- EPS
- VOR N/A
- WALD N/A
- Revenue
- VOR N/A
- WALD $274,560,000.00
- Revenue This Year
- VOR N/A
- WALD $10.37
- Revenue Next Year
- VOR N/A
- WALD $14.37
- P/E Ratio
- VOR N/A
- WALD N/A
- Revenue Growth
- VOR N/A
- WALD 14.22
- 52 Week Low
- VOR $2.62
- WALD $1.48
- 52 Week High
- VOR $65.80
- WALD $4.18
- Technical
- Relative Strength Index (RSI)
- VOR 26.51
- WALD 61.15
- Support Level
- VOR $7.60
- WALD $2.18
- Resistance Level
- VOR $8.77
- WALD $3.21
- Average True Range (ATR)
- VOR 0.98
- WALD 0.36
- MACD
- VOR -0.01
- WALD 0.07
- Stochastic Oscillator
- VOR 13.19
- WALD 56.41
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.